Expert Pitch
University of Georgia

Pandemic could make drug resistance epidemic worse

UGA expert says widespread antibiotic use could add fuel to the fire
8-Jul-2020 11:50 AM EDT, by University of Georgia

Before the COVID-19 pandemic hit, antibiotic resistance was turning minor infections into life-threatening emergencies. Stephen Trent, a University of Georgia researcher and antibiotic expert, said the pandemic could be adding fuel to the fire.

The CDC calls antibiotic resistance one of its top public health concerns, killing tens of thousands in the U.S. and more than 700,000 people worldwide each year. Reports from the United Nations predict that by 2050, 10 million people will die from antibiotic-resistant bacterial infections each year if nothing is done to stop the crisis.

“In the clinic, we have two pandemics going on at the same time,” said Trent, a UGA Foundation Distinguished Professor in the College of Veterinary Medicine. “We already had a global pandemic with antibiotic/antimicrobial resistance. There’s no doubt about that. Because of COVID, we’re giving a lot more patients antibiotics. We’re already seeing that we’re pushing the multidrug resistance problem and making that pandemic worse because we have to treat all of these people.”

Desperate measures
But with the onset of the coronavirus, health care professionals have become desperate to stave off secondary bacterial infections that often occur when patients are in hospitals for long periods of time. The lack of effective treatments for COVID also prompted many providers to prescribe antibiotics in a last-ditch effort to save their lives, even when there was no detectable bacterial infection for the drugs to fight. 

“If you’re an antibiotic researcher, you never, ever want someone getting an antibiotic without cause,” Trent said. “When you're pushing antibiotics in people even if they have COVID and there's no good reason to do that, you're asking for trouble.” 

Even before the pandemic, researchers were urging health care providers to assess whether a patient really needed antibiotics before prescribing them. But antibiotics had been the standard course of action in medicine for decades, and it’s proven a harder practice to overcome than expected.

The more exposure to antibiotics bacteria gets, the quicker it can evolve to overcome the drugs commonly used to treat it. Once it becomes resistant to common antibiotics, health care providers have limited options. And that means something as seemingly minor as a urinary tract infection can turn deadly. 

Secondary infections put doctors in a bind
The average COVID-19 patient is in the hospital for at least a week, and many end up on ventilators, exponentially upping their chances of developing a secondary bacterial infection on top of the coronavirus. Preliminary reports from China are estimating that about half the patients who die from COVID-19 had secondary infections.

“There is no doubt that there are more infections occurring in hospitals that are bacterial-based because of COVID,” Trent said. “There’s no doubt that it increases antibiotic use. And there’s no doubt that that is going to be a major problem worsening the antibiotic resistance problem we already have.”




Filters close

Showing results

110 of 5595
Released: 10-May-2021 3:05 PM EDT
Biomarker detects severe COVID-19 early on
University of Zurich

Most people who are infected with SARS-CoV-2 develop no or only mild symptoms.

Released: 10-May-2021 1:55 PM EDT
O filtro HEPA reduz as partículas respiratórias transportadas pelo ar geradas durante exercícios intensos
Mayo Clinic

Aerossóis respiratórios são um componente comum da respiração e são uma forma comum de vírus respiratórios, como o COVID-19 , se espalharem para outras pessoas e superfícies. Os pesquisadores que realizam testes de esforço físico para pacientes cardíacos na Mayo Clinic descobriram que praticar exercícios em níveis crescentes de esforço aumentava a concentração de aerossol no ambiente ao redor. Eles também descobriram que um filtro de ar particulado de alta eficiência (HEPA) filtrou de forma eficaz os aerossóis e diminuiu o tempo necessário para limpar o ar entre os pacientes.

access_time Embargo lifts in 2 days
Embargo will expire: 12-May-2021 12:05 AM EDT Released to reporters: 10-May-2021 1:15 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-May-2021 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-May-2021 1:05 PM EDT
El filtro HEPA reduce las partículas respiratorias transmitidas por el aire que se generan durante el ejercicio intenso
Mayo Clinic

Los aerosoles respiratorios son un componente común de la respiración y constituyen una vía común de propagación de virus respiratorios como la COVID-19 a personas y superficies. Los investigadores que realizan pruebas de esfuerzo físico en pacientes con problemas cardíacos en Mayo Clinic hallaron que el ejercicio a niveles mayores de esfuerzo aumentaba la concentración de aerosoles en el entorno circundante. Además, descubrieron que el filtro recogedor de partículas de alta eficiencia (HEPA, por sus siglas en inglés) descartaba de manera eficaz los aerosoles y disminuía el tiempo necesario para purificar el aire entre los pacientes.

Newswise:Video Embedded spray-protocol-increases-delivery-of-antiseptic-to-prevent-covid-19
VIDEO
Released: 10-May-2021 12:55 PM EDT
Spray protocol increases delivery of antiseptic to prevent COVID-19
South Dakota State University

A trip to visit family in India gave an SDSU researcher a unique opportunity to improve delivery of an antiseptic nasal spray to help prevent COVID-19.

access_time Embargo lifts in 2 days
Embargo will expire: 12-May-2021 5:00 AM EDT Released to reporters: 10-May-2021 10:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-May-2021 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 17-May-2021 10:00 AM EDT Released to reporters: 10-May-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-May-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 17-May-2021 3:30 PM EDT Released to reporters: 10-May-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-May-2021 3:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 19-May-2021 1:30 PM EDT Released to reporters: 10-May-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2021 1:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 16-May-2021 8:00 AM EDT Released to reporters: 10-May-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-May-2021 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 5595

close
1.32288